The appearance of sTn antigen is generally inextricably linked to the early occurrence of tumors, and it is expressed in bladder cancer (42), ovarian cancer (43), colon cancer (44), lung cancer (45), gastric cancer (46), and prostate cancer (47). Here, EEF1A2 is linked to urinary bladder carcinoma.